Ask AI
ProCE Banner Activity

An Expert’s Guide to ASCO 2025: Preview of the Top Abstracts

Conference Coverage
Clinical Thought

Experts highlight key studies being presented at the upcoming 2025 ASCO Annual Meeting. CCO’s Independent Conference Coverage will include timely summaries and practical implications of the latest research and developments in oncology to help you stay at the forefront of advances in cancer care.

Released: May 29, 2025

Expiration: November 28, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Breast Cancer: Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc, Gilead Sciences, Inc., Lilly, Novartis Pharmaceuticals Corporation, and Stemline Therapeutics, Inc.
Lung Cancer: Supported by educational grants from AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo, Inc, Genentech, a member of the Roche Group, and PharmaMar.
Lymphoma and Leukemia: Supported by an educational grant from Novartis Pharmaceuticals Corporation.
Genitourinary Cancer: Supported by an educational grant from Astellas.
Gastrointestinal Cancer: Supported by educational grants from Daiichi Sankyo, Inc. and Genentech, a member of the Roche Group.

Astellas

AstraZeneca

Boehringer Ingelheim Pharmaceuticals, Inc.

Daiichi Sankyo, Inc.

Genentech, a member of the Roche Group

Gilead Sciences, Inc.

Novartis Pharmaceuticals Corporation

PharmaMar

Stemline Therapeutics, Inc.

Disclosure

Primary Author

James M. Cleary, MD, PhD: consultant/advisor/speaker: Abdera, BeOne, Gilead, Prelude; researcher: Amgen, Arcus, BMS, GlaxoSmithKline, Merck, Merus, Pyxis, Servier; data and safety monitoring committee: AstraZeneca.

Patrick Forde, MD, PhD: researcher (paid to institution): AstraZeneca, BioNTech, Bristol Myers Squibb, Novartis, Regeneron; consultant: Amgen, Ascendis, AstraZeneca, BioNTech, Bristol Myers Squibb, Curevac, G1, Genelux, Genentech, Gritstone, F Star, Flame, Fosun, Iteos, Janssen, Merck, Novartis, Regeneron, Sanofi, Synthekine, Tavotek, Teva.

Kevin Kalinsky, MD, MS, FASCO: consultant/advisor/speaker: AstraZeneca, Daiichi Sankyo, Genentech/Roche, Gilead, Puma Biotechnology, Seattle Genetics.

Daniel P. Petrylak, MD: consultant/advisor/speaker: Ada Cap, Amgen, Astellas, AstraZeneca, Bayer, Bicycle Therapeutics, Boehringer Ingelheim, Bristol Myers Squibb, Clovis, Exelixis, Gilead, Incyte, Infinity, Ipsen, Janssen, Lilly, Merck, Mirati, Monopteros, Pfizer, Pharmacyclics, Regeneron, Roche, Sanofi Aventis, Seattle Genetics, UroGen; researcher: Ada Cap, Agensys, Arvinas, Astellas, AstraZeneca, Bayer, BioXcel Therapeutics, Bristol Myers Squibb, Clovis Oncology, Daiichi Sankyo, Eisai, Endocyte, Ferring, Genentech, Gilead, Innocrin, Lilly, MedImmune, Medivation, Merck, Mirati, Novartis, Pfizer, Progenics, Replimune, Roche, Sanofi Aventis, Seattle Genetics.

Zofia Piotrowaska, MD, MHS: consultant/advisor/speaker: AstraZeneca, Bayer, Blueprint Medicines, Boehringer Ingelheim, Daiichi Sankyo, Genentech, Janssen, Lilly, Merck, Sanofi, Taiho; researcher: AbbVie, AstraZeneca, Blueprint, Cullinan, Daiichi Sankyo, Janssen, Novartis, Nuvalent, SystImmune, Takeda, Tesaro/GlaxoSmithKline.

Sara M. Tolaney, MD, MPH: consultant/advisor/speaker: Aadi Bio, Artios, Arvinas, AstraZeneca, Bayer, BeiGene, Bicycle, BioNTech, Blueprint Medicines, Bristol Myers Squibb/SystImmune, Circle, Cullinan, Daiichi Sankyo, eFFECTOR, Eisai, Genentech/Roche, Gilead, Hengrui, Incyte, Jazz, Johnson & Johnson/Ambrx, Launch Therapeutics, Lilly, Menarini/Stemline, Merck, Mersana, Natera, Novartis, Pfizer, Reveal Genomics, Sanofi, Seattle Genetics, Sumitovant, Summit Therapeutics, Tango, Umoja Biopharma, Zentalis, Zuellig, Zymeworks; researcher (paid to institution): AstraZeneca, Bristol Myers Squibb/SystImmune, Cyclacel, Eisai, Exelixis, Genentech/Roche, Gilead, Jazz, Lilly, Menarini/Stemline, Merck, Nanostring, Novartis, OncoPep, Pfizer/Seattle Genetics.